Browse > Article
http://dx.doi.org/10.22246/jikm.2019.40.2.201

A Case Report of Efficacy of Saenggan-tang on a Patient with Drug Induced Liver Injury  

An, So-yeon (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Joo, Seong-hee (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Hur, So-yeong (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Jang, Eun-gyeong (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Lee, Jang-hoon (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Kim, Young-chul (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Publication Information
The Journal of Internal Korean Medicine / v.40, no.2, 2019 , pp. 201-207 More about this Journal
Abstract
Objectives: The purpose of this case study is to report the effect of Korean Medicine treatment on a patient diagnosed with drug-induced liver injury by oral administration of acetaminophen. Methods: A 21-year-old male patient with drug-induced liver injury visited the clinic five times from January 28th, 2019 to March 16th, 2019. The patient took Saenggan-tang extract during the treatment period. Results: The levels of serum alanine aminotransferase (ALT) and gamma-glutamyl transferase (GGT) were significantly decreased. The chief complaints of the patient, such as yellow-red urine and fatigue, were also relieved. Conclusion: Traditional Korean medicine has a beneficial effect on drug-induced liver injury.
Keywords
drug induced liver injury; acetaminophen; paracetamol; hepatotoxicity; liver function test; Saenggan-tang;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Vuppalanchi R, Liangpunsakul S, Chalasani N. Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States? Am J Gastroenterol 2007;102(3):558-62.   DOI
2 Fisher K, Vuppalanchi R, Saxena R. Drug-Induced Liver Injury. Arch Pathol Lab Med 2015;139(7):876-87.   DOI
3 Ki TS, Kim DJ. Drug-induced liver injury: present and future. Clin Mol Hepatol 2012;18(3):249-57.   DOI
4 Shen T, Liu Y, Shang J, Xie Q, Li J, Yan M, et al. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. Gastroenterology 2019;156(8):2230-41.   DOI
5 Lee WM. Drug-induced acute liver failure. Clin Liver Dis2013;17(4):575-86.   DOI
6 Yun YJ, Shin BC, Lee MS, Cho SI, Park JH, Lee HJ. Systematic Review of the Cause of Drug-Induced Liver Injuries in Korean Literature. J Korean Oriental Med 2009;30(2):30-45.
7 Lee BM, Lee WC, Jang JY, Ahn P, Kim JN, Jeong SW, et al. Clinical Features of Drug-induced Liver Injury According to Etiology. J Korean Med Sci 2015;30(12):1815-20.   DOI
8 Hussaini SH, Farrington EA. Idiosyncratic drug-induced liver injury: an update on the 2007 overview. Expert Opin Drug Saf 2014;13(1):67-81.   DOI
9 Anee M. Acetaminophen Hepatotoxicity. Clin Liver Dis2007;11(3):525-48.   DOI
10 Caparrotta TM, Antoine DJ, Dear JW. Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature. Eur J Clin Pharmacol 2018;74(2):147-60.   DOI
11 Duan L, Davis JS, Woolbright BL, Du K, Cahkraborty M, Weemhoff J, et al. Differential Susceptibility to Acetaminophen-Induced Liver Injury in Sub-Strains of C57BL/6 Mice: 6N versus 6J. Food Chem Toxicol 2016;98:107-18.   DOI
12 Gamal W, Treskes P, Samuel K, Sullivan GJ, Siller R, Srsen V, et al. Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liver. Sci Rep 2017;7:37541.   DOI
13 Hu J, Ramshesh VK, McGill MR, Jaeschke H, Lemasters JJ. Low Dose Acetaminophen Induces Reversible Mitochondrial Dysfunction Associated with Transient c-Jun N-Terminal Kinase Activation in Mouse Liver. Toxicol Sci 2016;150(1):204-15.   DOI
14 Yi SR, Noh HI, Yoon DR, Lee IH, Ryu JH. A Case Report of Korean Medicine Treatment for Drug-induced Liver Injury by Antiepileptics. Korean J Intern Med 2013;fal:285-9.
15 Yoo JY, Lee JH. Effect of saenggantanggami-bang on nonalcoholic fatty liver disease induced by fatty acid. Korean J Intern Med 2010;31(2):331-45.
16 Seung HS, Park SM, Han CW, Kim YC, Lee JH, Woo HJ. Two Cases of Hepatitis Treated with Gagamsaenggan-tang. Korean J Intern Med 2002;23(2):228-37.
17 Jang EG, Kim BJ, Lee KT, Inn KS, Lee JH. A Survey of Therapeutic Effects of Artemisia capillaris in Liver Diseases. Evid Based Complement Alternat Med 2015;2015:728137.